{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:45:23Z","timestamp":1790963123840,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.canlet.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T23:39:31Z","timestamp":1628638771000},"page":"361-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways"],"prefix":"10.1016","volume":"520","author":[{"given":"Leonie","family":"Sch\u00fcrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Roquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-2173","authenticated-orcid":false,"given":"Anamaria","family":"Brozovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canlet.2021.08.006_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","article-title":"The DNA damage response: ten years after","volume":"28","author":"Harper","year":"2007","journal-title":"Mol. Cell."},{"issue":"5828","key":"10.1016\/j.canlet.2021.08.006_bib52","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0959-437X(00)00159-3","article-title":"ATM and ATR: networking cellular responses to DNA damage","volume":"11","author":"Shiloh","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0955-0674(00)00201-5","article-title":"DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?","volume":"13","author":"Durocher","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"12","key":"10.1016\/j.canlet.2021.08.006_bib47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4161\/cc.5.12.2834","article-title":"How cells activate ATR","volume":"5","author":"Kumagai","year":"2006","journal-title":"Cell Cycle"},{"issue":"19","key":"10.1016\/j.canlet.2021.08.006_bib65","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4161\/cc.5.19.3256","article-title":"Evidence that the ATR\/Chk1 pathway maintains normal replication fork progression during unperturbed S phase","volume":"5","author":"Petermann","year":"2006","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Canc."},{"issue":"24","key":"10.1016\/j.canlet.2021.08.006_bib2","doi-asserted-by":"crossref","first-page":"11886","DOI":"10.1158\/0008-5472.CAN-07-2964","article-title":"Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks","volume":"67","author":"Batista","year":"2007","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/cdd.2015.75","article-title":"HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism","volume":"23","author":"Conrad","year":"2016","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncb715","article-title":"Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2","volume":"4","author":"Hofmann","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"15","key":"10.1016\/j.canlet.2021.08.006_bib53","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s00018-016-2130-4","article-title":"The DNA damage-induced cell death response: a roadmap to kill cancer cells","volume":"73","author":"Matt","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2021.08.006_bib22","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-13-0136","article-title":"Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide","author":"Eich","year":"2013","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2021.08.006_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2017.08.013","article-title":"DNA damage response inhibitors: mechanisms and potential applications in cancer therapy","volume":"60","author":"Carrassa","year":"2017","journal-title":"Canc. Treat Rev."},{"issue":"6","key":"10.1016\/j.canlet.2021.08.006_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrd4553","article-title":"Exploiting replicative stress to treat cancer","volume":"14","author":"Dobbelstein","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.canlet.2021.08.006_bib58","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","article-title":"Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways","volume":"21","author":"Morgan","year":"2015","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2021.08.006_bib82","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pharmthera.2014.12.001","article-title":"ATM and ATR as therapeutic targets in cancer","volume":"149","author":"Weber","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.canlet.2021.08.006_bib60","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/nsmb.2189","article-title":"Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors","volume":"18","author":"Murga","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.canlet.2021.08.006_bib71","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3865","article-title":"Wee1 is required to sustain ATR\/Chk1 signaling upon replicative stress","author":"Saini","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.canlet.2021.08.006_bib79","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.molonc.2011.07.002","article-title":"Targeting ATR and Chk1 kinases for cancer treatment: a new model for new (and old) drugs","volume":"5","author":"Toledo","year":"2011","journal-title":"Mol. Oncol."},{"issue":"23","key":"10.1016\/j.canlet.2021.08.006_bib85","doi-asserted-by":"crossref","first-page":"34688","DOI":"10.18632\/oncotarget.9156","article-title":"Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.canlet.2021.08.006_bib28","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1158\/0008-5472.CAN-10-2286","article-title":"Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner","volume":"70","author":"Gilad","year":"2010","journal-title":"Canc. Res."},{"issue":"4","key":"10.1016\/j.canlet.2021.08.006_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.molonc.2011.07.001","article-title":"The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings","volume":"5","author":"Helleday","year":"2011","journal-title":"Mol. Oncol."},{"issue":"6330","key":"10.1016\/j.canlet.2021.08.006_bib49","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"issue":"7035","key":"10.1016\/j.canlet.2021.08.006_bib23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.08.006_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-med-050913-022545","article-title":"Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors","volume":"66","author":"Lord","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0960-9822(99)80047-5","article-title":"Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes","volume":"9","author":"Durant","year":"1999","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib24","first-page":"1","article-title":"The role of DNA mismatch repair in drug resistance","volume":"4","author":"Fink","year":"1998","journal-title":"Clin. Canc. Res."},{"issue":"4","key":"10.1016\/j.canlet.2021.08.006_bib26","article-title":"Mismatch repair protein loss is a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability","volume":"79","author":"Fusco","year":"2019","journal-title":"Canc. Res."},{"issue":"11","key":"10.1016\/j.canlet.2021.08.006_bib83","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1097\/PAS.0b013e3182627787","article-title":"DNA mismatch repair deficiency in breast carcinoma A pilot study of triple-negative and non-triple-negative tumors","volume":"36","author":"Wen","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.canlet.2021.08.006_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11010-015-2636-3","article-title":"Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines","volume":"412","author":"Hassen","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"17","key":"10.1016\/j.canlet.2021.08.006_bib62","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.canlet.2021.08.006_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.canlet.2021.08.006_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00412-009-0234-4","article-title":"H2AX: functional roles and potential applications","volume":"118","author":"Dickey","year":"2009","journal-title":"Chromosoma"},{"issue":"17","key":"10.1016\/j.canlet.2021.08.006_bib46","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1093\/nar\/gkn550","article-title":"Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin","volume":"36","author":"Kinner","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2021.08.006_bib63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0091-679X(04)75014-1","article-title":"Detection of DNA damage in individual cells by analysis of histone H2AX phosphorylation","volume":"75","author":"Olive","year":"2004","journal-title":"Methods Cell Biol."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib67","first-page":"168","article-title":"Recent developments in the use of gamma-H2AX as a quantitative DNA double-strand break biomarker","volume":"3","author":"Redon","year":"2011","journal-title":"Aging (N Y)"},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","article-title":"53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks","volume":"141","author":"Bunting","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.canlet.2021.08.006_bib43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10409238.2019.1620676","article-title":"Preserving genome integrity and function: the DNA damage response and histone modifications","volume":"54","author":"Kim","year":"2019","journal-title":"Crit. Rev. Biochem. Mol."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib87","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tcb.2013.09.003","article-title":"53BP1: pro choice in DNA repair","volume":"24","author":"Zimmermann","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2021.08.006_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03096-0","article-title":"HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130","volume":"9","author":"Goder","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.canlet.2021.08.006_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011208","article-title":"Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor","volume":"5","author":"Kachhap","year":"2010","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.canlet.2021.08.006_bib61","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.tips.2017.05.009","article-title":"Interstrand crosslink repair as a target for HDAC inhibition","volume":"38","author":"Nikolova","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.canlet.2021.08.006_bib86","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.18632\/oncotarget.14062","article-title":"Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib48","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1016\/S1470-2045(18)30786-1","article-title":"Exploring and comparing adverse events between PARP inhibitors","volume":"20","author":"LaFargue","year":"2019","journal-title":"Lancet Oncol."},{"issue":"21","key":"10.1016\/j.canlet.2021.08.006_bib81","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1093\/nar\/gkl840","article-title":"PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways","volume":"34","author":"Wang","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"7713","key":"10.1016\/j.canlet.2021.08.006_bib54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-018-0261-5","article-title":"High speed of fork progression induces DNA replication stress and genomic instability","volume":"559","author":"Maya-Mendoza","year":"2018","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.canlet.2021.08.006_bib10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.chembiol.2015.10.003","article-title":"Small-Molecule disruption of RAD52 rings as a mechanism for precision medicine in BRCA-deficient cancers","volume":"22","author":"Chandramouly","year":"2015","journal-title":"Chem. Biol."},{"issue":"9","key":"10.1016\/j.canlet.2021.08.006_bib37","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1093\/nar\/gkw087","article-title":"Targeting BRCA1-and BRCA2-deficient cells with RAD52 small molecule inhibitors","volume":"44","author":"Huang","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nchembio.63","article-title":"A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex","volume":"4","author":"Dupre","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"15","key":"10.1016\/j.canlet.2021.08.006_bib5","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1093\/nar\/gks353","article-title":"RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells","volume":"40","author":"Budke","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.canlet.2021.08.006_bib40","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/cb100428c","article-title":"Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening","volume":"6","author":"Huang","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"26","key":"10.1016\/j.canlet.2021.08.006_bib51","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1073\/pnas.0603779103","article-title":"H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks","volume":"103","author":"Marti","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.canlet.2021.08.006_bib15","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00018-017-2702-y","article-title":"Homologous recombination-mediated repair of DNA double-strand breaks operates in mammalian mitochondria","volume":"75","author":"Dahal","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.canlet.2012.01.007","article-title":"DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis","volume":"332","author":"Roos","year":"2013","journal-title":"Canc. Lett."},{"issue":"35","key":"10.1016\/j.canlet.2021.08.006_bib64","doi-asserted-by":"crossref","first-page":"14491","DOI":"10.1073\/pnas.1102295108","article-title":"Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein","volume":"108","author":"Otterbein","year":"2011","journal-title":"P. Natl. Acad. Sci. U.S.A."},{"issue":"21","key":"10.1016\/j.canlet.2021.08.006_bib69","first-page":"10017","article-title":"The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair","volume":"44","author":"Roos","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"10.1016\/j.canlet.2021.08.006_bib59","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by clinical PARP inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2021.08.006_bib77","article-title":"Preclinical pharmacokinetic and efficacy modeling of parp inhibitors niraparib and olaparib","volume":"28","author":"Sun","year":"2018","journal-title":"Int. J. Gynecol. Canc."},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib78","article-title":"A comparative pharmacokinetic-pharmacodynamic-treatment study of PARP inhibitors demonstrates favorable properties for niraparib activity in preclinical tumor models","volume":"17","author":"Sun","year":"2018","journal-title":"Mol. Canc. Therapeut."},{"issue":"11","key":"10.1016\/j.canlet.2021.08.006_bib3","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1158\/1535-7163.MCT-16-0176","article-title":"Targeting homologous recombination by pharmacological inhibitors enhances the killing response of glioblastoma cells treated with alkylating drugs","volume":"15","author":"Berte","year":"2016","journal-title":"Mol. Canc. Therapeut."},{"issue":"7","key":"10.1016\/j.canlet.2021.08.006_bib39","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1021\/jm201173g","article-title":"Inhibition of homologous recombination in human cells by targeting RAD51 recombinase","volume":"55","author":"Huang","year":"2012","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.canlet.2021.08.006_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/cas.12717","article-title":"Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage","volume":"106","author":"Fukuda","year":"2015","journal-title":"Canc. Sci."},{"issue":"9","key":"10.1016\/j.canlet.2021.08.006_bib56","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nsmb.1899","article-title":"Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining","volume":"17","author":"Miller","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nchembio.63","article-title":"A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex","volume":"4","author":"Dupre","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.canlet.2021.08.006_bib14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/MCB.22.3.874-885.2002","article-title":"Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian aurora kinases","volume":"22","author":"Crosio","year":"2002","journal-title":"Mol. Cell Biol."},{"issue":"39","key":"10.1016\/j.canlet.2021.08.006_bib44","doi-asserted-by":"crossref","first-page":"65064","DOI":"10.18632\/oncotarget.17775","article-title":"The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: a comparative study with Ki67","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.canlet.2021.08.006_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100993","article-title":"A small molecule inhibitor of human RAD51 potentiates breast cancer cell killing by therapeutic agents in mouse xenografts","volume":"9","author":"Huang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2021.08.006_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fonc.2014.00289","article-title":"A small-molecule inhibitor of RAD51 reduces homologous recombination and sensitizes multiple myeloma cells to doxorubicin","volume":"4","author":"Alagpulinsa","year":"2014","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stemcr.2016.12.005","article-title":"RAD51 is a selective DNA repair target to radiosensitize glioma stem cells","volume":"8","author":"King","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.canlet.2021.08.006_bib41","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3892\/or.2015.4488","article-title":"Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy","volume":"35","author":"Ihara","year":"2016","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib12","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1038\/s41467-019-12594-8","article-title":"5-Fluorouracil treatment induces characteristic T>G mutations in human cancer","volume":"10","author":"Christensen","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2021.08.006_bib31","doi-asserted-by":"crossref","first-page":"zcaa024","DOI":"10.1093\/narcan\/zcaa024","article-title":"Regulation and pharmacological targeting of RAD51 in cancer","volume":"2","author":"Grundy","year":"2020","journal-title":"NAR Canc."},{"issue":"4","key":"10.1016\/j.canlet.2021.08.006_bib74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10495-010-0564-y","article-title":"Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage","volume":"16","author":"Schonn","year":"2011","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.canlet.2021.08.006_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1005484004167","article-title":"Mitochondrial DNA repair pathways","volume":"31","author":"Bohr","year":"1999","journal-title":"J. Bioenerg. Biomembr."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib72","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1152\/physrev.00025.2007","article-title":"Transcriptional paradigms in mammalian mitochondrial biogenesis and function","volume":"88","author":"Scarpulla","year":"2008","journal-title":"Physiol. Rev."},{"issue":"9\u201310","key":"10.1016\/j.canlet.2021.08.006_bib73","first-page":"1088","article-title":"Nucleus-encoded regulators of mitochondrial function: integration of respiratory chain expression, nutrient sensing and metabolic stress","volume":"1819","author":"Scarpulla","year":"2012","journal-title":"Bba-Gene Regul. Mech."},{"key":"10.1016\/j.canlet.2021.08.006_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-2018-y","article-title":"MLH1 deficiency leads to deregulated mitochondrial metabolism","volume":"10","author":"Rashid","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib84","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"7\u20138","key":"10.1016\/j.canlet.2021.08.006_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.exger.2010.01.017","article-title":"Mitochondrial DNA repair and association with aging - an update","volume":"45","author":"Gredilla","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/labinvest.3780230","article-title":"Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer","volume":"81","author":"Burri","year":"2001","journal-title":"Lab. Invest."},{"issue":"5","key":"10.1016\/j.canlet.2021.08.006_bib32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0016-5085(99)70009-0","article-title":"Association of K-ras mutations with p16 methylation in human colon cancer","volume":"116","author":"Guan","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2021.08.006_bib57","doi-asserted-by":"crossref","first-page":"951574","DOI":"10.1155\/2012\/951574","article-title":"Role of p16(INK4A) in replicative senescence and DNA damage-induced premature senescence in p53-deficient human cells","volume":"2012","author":"Mirzayans","year":"2012","journal-title":"Biochem. Res. Int."},{"issue":"9","key":"10.1016\/j.canlet.2021.08.006_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092019","article-title":"Oxaliplatin-induced senescence in colorectal cancer cells depends on p14(ARF)-Mediated sustained p53 activation","volume":"13","author":"Tomicic","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2021.08.006_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.03.016","article-title":"Doxorubicin targets multiple players: a new view of an old problem","volume":"127","author":"Cappetta","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.canlet.2021.08.006_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.canlet.2021.08.006_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"2","key":"10.1016\/j.canlet.2021.08.006_bib75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.4.2.219","article-title":"Toxicity of the topoisomerase II inhibitors","volume":"4","author":"Seiter","year":"2005","journal-title":"Expet Opin. Drug Saf."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521003955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521003955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:02:40Z","timestamp":1759593760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521003955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":87,"alternative-id":["S0304383521003955"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.08.006","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}